| Product Code: ETC13230674 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Achalasia Cardia Market was valued at USD 0.15 Billion in 2024 and is expected to reach USD 0.28 Billion by 2031, growing at a compound annual growth rate of 7.70% during the forecast period (2025-2031).
The global Achalasia Cardia market is a niche segment within the gastrointestinal disorders market, characterized by the inability of the esophagus to move food into the stomach due to the lower esophageal sphincter not relaxing properly. The market is driven by factors such as increasing awareness about the disorder, advancements in diagnostic techniques, and rising prevalence of esophageal diseases. Key players in the market are focusing on developing innovative treatment options such as pneumatic dilation, surgical myotomy, and peroral endoscopic myotomy. North America and Europe hold significant market shares due to better healthcare infrastructure and higher diagnosis rates, while Asia-Pacific is expected to witness substantial growth due to improving healthcare facilities and increasing prevalence of Achalasia Cardia in the region. The market is highly competitive, with players focusing on research and development to introduce more effective treatment options.
The Global Achalasia Cardia Market is witnessing significant growth driven by increased awareness, improved diagnostic techniques, and advancements in treatment options such as minimally invasive procedures. The market is also benefiting from the rising prevalence of achalasia cardia due to factors like changing dietary habits and an aging population. Opportunities in the market include the development of innovative therapies, expansion into emerging markets, and strategic partnerships to enhance product offerings. Additionally, the adoption of telemedicine and digital health solutions for remote monitoring and follow-up care presents a promising avenue for market growth. Overall, the Global Achalasia Cardia Market is poised for expansion with a focus on patient-centric care and technological advancements.
The Global Achalasia Cardia Market faces several challenges, including limited awareness about the condition among healthcare professionals and patients, resulting in underdiagnosis and delayed treatment. Additionally, the lack of definitive diagnostic tests for achalasia can lead to misdiagnosis or delayed diagnosis, further complicating patient management. Treatment options for achalasia, such as pneumatic dilation and surgical myotomy, carry potential risks and complications, making the decision-making process challenging for both patients and physicians. Moreover, the high cost of treatment, especially in developing countries, can act as a barrier to accessing appropriate care for individuals with achalasia. Overall, addressing these challenges through increased awareness, improved diagnostic methods, and cost-effective treatment options is essential to enhance outcomes for patients with achalasia.
The global Achalasia Cardia market is primarily driven by the increasing prevalence of achalasia cases worldwide, leading to a growing demand for diagnosis and treatment options. Technological advancements in diagnostic procedures and treatment methods, such as minimally invasive surgeries and endoscopic therapies, are fueling market growth by offering more effective and less invasive options for patients. Additionally, the rising awareness about the disorder among healthcare professionals and patients, along with improved healthcare infrastructure in developing countries, are contributing to the expansion of the Achalasia Cardia market. Furthermore, initiatives by government organizations and healthcare providers to enhance early detection and treatment of achalasia are expected to further propel market growth in the coming years.
Government policies related to the Global Achalasia Cardia Market primarily focus on ensuring patient access to diagnosis and treatment, promoting research and development for innovative therapies, and regulating healthcare providers to maintain quality standards. These policies may include funding support for research on achalasia cardia, reimbursement schemes to cover medical expenses for patients, and guidelines for healthcare facilities to adhere to best practices in diagnosis and treatment. Additionally, regulatory bodies may oversee the approval and monitoring of medical devices and drugs used in the management of achalasia cardia to ensure safety and efficacy. Overall, government policies aim to improve patient outcomes, drive advancements in treatment options, and safeguard public health in the Global Achalasia Cardia Market.
The Global Achalasia Cardia Market is expected to witness steady growth in the coming years due to increasing awareness, improved diagnosis techniques, and advancements in treatment options. A rising prevalence of achalasia, a rare esophageal motility disorder, coupled with an aging population, is driving market growth. Technological innovations such as minimally invasive surgical procedures and the development of novel therapies are anticipated to further propel market expansion. Additionally, the adoption of telemedicine services in the healthcare sector is likely to enhance patient access to treatment options, fostering market growth. However, challenges such as high treatment costs and limited awareness in developing regions may hinder market growth to some extent. Overall, the Global Achalasia Cardia Market is poised for significant development in the foreseeable future.
In the global Achalasia Cardia market, Asia is expected to witness significant growth due to the increasing awareness about the condition and rising healthcare expenditure in countries like China and India. North America is projected to hold a substantial market share owing to the presence of advanced healthcare infrastructure and a high prevalence of esophageal disorders. Europe is also anticipated to contribute significantly to the market growth with a focus on research and development activities. The Middle East and Africa region is likely to experience moderate growth due to improving healthcare facilities and rising cases of esophageal disorders. Latin America is forecasted to show steady growth, driven by increasing healthcare investments and a growing patient population with Achalasia Cardia.
Global Achalasia Cardia Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Achalasia Cardia Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Achalasia Cardia Market Revenues & Volume, 2021 & 2031F |
3.3 Global Achalasia Cardia Market - Industry Life Cycle |
3.4 Global Achalasia Cardia Market - Porter's Five Forces |
3.5 Global Achalasia Cardia Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Achalasia Cardia Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Global Achalasia Cardia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Global Achalasia Cardia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Global Achalasia Cardia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Achalasia Cardia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Achalasia Cardia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Achalasia Cardia Market Trends |
6 Global Achalasia Cardia Market, 2021 - 2031 |
6.1 Global Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Achalasia Cardia Market, Revenues & Volume, By TypeI, 2021 - 2031 |
6.1.3 Global Achalasia Cardia Market, Revenues & Volume, By TypeII, 2021 - 2031 |
6.1.4 Global Achalasia Cardia Market, Revenues & Volume, By TypeIII, 2021 - 2031 |
6.2 Global Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Achalasia Cardia Market, Revenues & Volume, By High Resolution Oesophageal Topography, 2021 - 2031 |
6.2.3 Global Achalasia Cardia Market, Revenues & Volume, By Endoscopy, 2021 - 2031 |
6.3 Global Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Achalasia Cardia Market, Revenues & Volume, By Botulinum Toxin, 2021 - 2031 |
6.3.3 Global Achalasia Cardia Market, Revenues & Volume, By Pneumatic Balloon Dilation, 2021 - 2031 |
6.3.4 Global Achalasia Cardia Market, Revenues & Volume, By Laparoscopic Heller Myotomy, 2021 - 2031 |
6.4 Global Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Achalasia Cardia Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.3 Global Achalasia Cardia Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 Global Achalasia Cardia Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.4.5 Global Achalasia Cardia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Achalasia Cardia Market, Revenues & Volume, By Direct Tenders, 2021 - 2031 |
6.5.3 Global Achalasia Cardia Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.4 Global Achalasia Cardia Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.5 Global Achalasia Cardia Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.6 Global Achalasia Cardia Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Achalasia Cardia Market, Overview & Analysis |
7.1 North America Achalasia Cardia Market Revenues & Volume, 2021 - 2031 |
7.2 North America Achalasia Cardia Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 North America Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.6 North America Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Achalasia Cardia Market, Overview & Analysis |
8.1 Latin America (LATAM) Achalasia Cardia Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Achalasia Cardia Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
8.4 Latin America (LATAM) Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.5 Latin America (LATAM) Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.6 Latin America (LATAM) Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Achalasia Cardia Market, Overview & Analysis |
9.1 Asia Achalasia Cardia Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Achalasia Cardia Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
9.4 Asia Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.5 Asia Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.6 Asia Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Achalasia Cardia Market, Overview & Analysis |
10.1 Africa Achalasia Cardia Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Achalasia Cardia Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
10.4 Africa Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.5 Africa Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.6 Africa Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Achalasia Cardia Market, Overview & Analysis |
11.1 Europe Achalasia Cardia Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Achalasia Cardia Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
11.4 Europe Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.5 Europe Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.6 Europe Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Achalasia Cardia Market, Overview & Analysis |
12.1 Middle East Achalasia Cardia Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Achalasia Cardia Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Achalasia Cardia Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Achalasia Cardia Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
12.4 Middle East Achalasia Cardia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.5 Middle East Achalasia Cardia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.6 Middle East Achalasia Cardia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Achalasia Cardia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Achalasia Cardia Market Key Performance Indicators |
14 Global Achalasia Cardia Market - Export/Import By Countries Assessment |
15 Global Achalasia Cardia Market - Opportunity Assessment |
15.1 Global Achalasia Cardia Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Achalasia Cardia Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
15.3 Global Achalasia Cardia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.4 Global Achalasia Cardia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.5 Global Achalasia Cardia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Achalasia Cardia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Achalasia Cardia Market - Competitive Landscape |
16.1 Global Achalasia Cardia Market Revenue Share, By Companies, 2024 |
16.2 Global Achalasia Cardia Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here